ClinicalTrialsFinder

Residual Disease Clinical Trials in New York, New York

1 recruitingNew York, New York

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

A Study of Tetrathiomolybdate (TM) Plus Capecitabine

Triple-Negative Breast CancerResidual Disease
Dartmouth-Hitchcock Medical Center204 enrolled3 locationsNCT06134375